Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Oct 05, 2023	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-23-107161.pdf 0001104659-23-107161.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Oct 03, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-23-000395.pdf
Oct 03, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-23-000035.pdf 0001968202-23-000035.xls
Oct 02, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-004359.pdf 0001950047-23-004359.xls
Sep 27, 2023	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001104659-23-104277.pdf 0001104659-23-104277.xls
Sep 25, 2023	SC TO-T/A	Amendment to a previously filed SC TO-T	View HTML 0001104659-23-103362.pdf 0001104659-23-103362.xls
Sep 12, 2023	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001104659-23-099983.pdf 0001104659-23-099983.xls
Sep 12, 2023	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001104659-23-099984.pdf 0001104659-23-099984.xls
Sep 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-099988.pdf 0001104659-23-099988.xls
Sep 12, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001104659-23-099992.pdf 0001104659-23-099992.xls

Data provided by Kaleidoscope.

Investors & Media